SCHEMBL26319645

SCHEMBL26319645

CCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCN(CCC)CCCCCCCC(=O)N(C)CCCCCCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.48
MAPT P10636 2/20 0.48
EPHX2 P34913 2/20 0.46
LMNA P02545 4/20 0.46
ALDH1A1 P00352 1/20 0.46
PRKCA P17252 1/20 0.43
PRKCE Q02156 1/20 0.43
PRKCQ Q04759 1/20 0.43
PRKCD Q05655 1/20 0.43
KDM5A P29375 4/20 0.42
PHF8 Q9UPP1 2/20 0.42
KDM4C Q9H3R0 1/20 0.42
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
MEN1 O00255 1/20 0.40
GMNN O75496 1/20 0.40
HSP90AA1 P07900 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26319651 1.00 MAPK1 (0.48) MAPK1MAPTEPHX2LMNAALDH1A1
SCHEMBL18665089 0.93 MAPT (0.49) MAPK1MAPTEPHX2LMNAALDH1A1
SCHEMBL18665197 0.93 MAPT (0.49) MAPK1MAPTEPHX2LMNAALDH1A1
SCHEMBL22646140 0.93 MAPT (0.49) MAPK1MAPTEPHX2LMNAALDH1A1
SCHEMBL20892181 0.93 MAPT (0.49) MAPK1MAPTEPHX2LMNAALDH1A1
SCHEMBL18641714 0.93 MAPT (0.49) MAPK1MAPTEPHX2LMNAALDH1A1
SCHEMBL26734015 0.93 MAPT (0.48) MAPK1MAPTEPHX2LMNAALDH1A1
SCHEMBL26735135 0.93 MAPT (0.48) MAPK1MAPTEPHX2LMNAALDH1A1
SCHEMBL26735108 0.93 MAPT (0.48) MAPK1MAPTEPHX2LMNAALDH1A1
SCHEMBL29292166 0.91 MAPK1 (0.57) MAPK1MAPTLMNAALDH1A1PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230270685-A1 POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASE MODERNATX, INC. (US) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230270685-A1 POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASE POLM, EMG1, MCM6 MAPK1 4072/4885MAPT 3723/4885EPHX2 3816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.